Medical Services related to Steven Eldon Gay MD

COPD Clinic

The Michigan Medicine COPD Clinic has multi-disciplinary expertise including physicians, nursing, respiratory therapy, social work and nutrition all co-located and available at the point of care to meet patients' individual needs.  We have developed a standardized assessment but are prepared to develop individual therapy plans  Patients will also be evaluated, if they desire, for potential participation in clinical trials being conducted in COPD at the University of Michigan. Evaluation also includes referral to our lung volume reduction surgery and lung transplant programs if needed.

Hereditary Hemorrhagic Telangiectasia (HHT)

Hereditary Hemorrhagic Telangiectasia  (HHT) is a genetic disorder that affects about one in 5,000 people and commonly causes nosebleeds, with more frequent nosebleeds typically starting after about age 12.  Patients with HHT have a tendency to form blood vessels that are abnormal, fragile, and bleed more easily. 

Hereditary Hemorrhagic Telangiectasia (HHT) Treatment

There are many different specialists who treat patients with HHT. Many patients will eventually see two or more types of specialists, especially later in adulthood. Specialists who treat HHT include otolaryngologists (ear, nose & throat doctors), interventional radiologists (to treat AVMs), hematologists (to help manage anemia), and more.

Lung Disease and Respiratory Care (Pulmonary)

Pulmonary Diseases and Critical Care physicians at the University of Michigan focus on pulmonary (lungs and breathing) disorders and critical illnesses (conditions such as shock, respiratory failure, and multiple organ failure). Our multidisciplinary teams treat the full scope of pulmonary issues including asthma, COPD and emphysema and cystic fibrosis.

Lung Transplant

The University of Michigan Transplant Center is the largest and most experienced lung transplant center in Michigan, and among the largest in the nation, with 20-40 lung transplants performed each year, and patient survival rate at one year at 90% – and we offer services that are not available widely, including Ambulatory ECMO (Extracorporeal Membrane Oxygenation) – an alternative to a ventilator that allows patients waiting for lung transplant to remain active and stay healthier, plus novel clinical trials available in few centers across the U.S.

Lung Transplant Patient Care Guide

The PDF links on this page link to material in the University of Michigan Lung Transplant Patient Education Guide and allow you to view and print the information on your own computer.

Lung Transplant Process

The University of Michigan Transplant Center is the largest and most experienced transplant center in Michigan, and among the largest in the nation, with 20-40 lungs transplants performed each year, and patient survival rate at one year at 90% – and we offer services that are not available widely, including Ambulatory ECMO (Extracorporeal Membrane Oxygenation) – an alternative to a ventilator that allows patients waiting for lung transplant to remain active and stay healthier, plus novel clinical trials available in few centers across the U.S.

Lung Transplant Videos

The University of Michigan Transplant Center is the largest and most experienced transplant center in Michigan, and among the largest in the nation, with 20-40 lungs transplants performed each year, and patient survival rate at one year at 90% – and we offer services that are not available widely, including Ambulatory ECMO (Extracorporeal Membrane Oxygenation) – an alternative to a ventilator that allows patients waiting for lung transplant to remain active and stay healthier, plus novel clinical trials available in few centers across the U.S.

Michigan Airways Program

The goal of the University of Michigan Airways Program (MAP) is to improve the lives of patients with airways disease by accessing our strength in airways research to accelerate the development of personalized patient therapies.